Novel Endpoints in Cancer Care: What Lies Ahead

Malik Kaman

Malik Kaman, Associate Principal, Oncology, ZS Associates, sits down with Lee S. Schwartzberg, MD, Executive Director, West Cancer Center, Chief, Professor of Medicine, Division of Hematology/Oncology, the University of Tennessee Health Science Center, to discuss what lies ahead for novel endpoints in cancer care.

Related Videos

CAR-T Center and Patients

How Can a CAR-T Center Get Established and Effectively Treat Patients

Manufacturers and CAR-T

How Can Manufacturers Help Institutions Prepare for CAR-T Therapies

Future of CAR-T therapies

Will Tomorrow's CAR-T Therapy Innovations Solve Today's Challenges

Next-Gen Sequencing

Next-Gen Sequencing is Transforming Oncology Practices

NGS-Based Cancer Tests

Will NGS Based Cancer Tests Become Routine

Hazards of Misinformation

Oncology Clinical Trials

Future of Cancer Care